Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels

NCT03335501 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The owner of the algorithm does not wish that this study be undertaken

Conditions

Type 1 Diabetes Mellitus

Interventions

DEVICE: Insulin pump
DEVICE: Continuous glucose monitoring system
OTHER: 11-hour intervention with the single-hormone artificial pancreas

Sponsor

Institut de Recherches Cliniques de Montreal